Published in Circulation on November 01, 1996
Remote ischaemic pre- and delayed postconditioning - similar degree of cardioprotection but distinct mechanisms. Exp Physiol (2012) 1.80
Remote ischemic conditioning. J Am Coll Cardiol (2015) 1.66
Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart (2007) 1.30
Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc Res (2012) 1.23
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc Natl Acad Sci U S A (2013) 1.12
Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res (2009) 1.10
Remote ischemic preconditioning delays the onset of acute mountain sickness in normobaric hypoxia. Physiol Rep (2015) 1.09
Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol (2016) 1.08
AKI associated with cardiac surgery. Clin J Am Soc Nephrol (2014) 1.08
Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option? J Am Soc Nephrol (2013) 1.07
Remote ischemic preconditioning (RIPC) modifies plasma proteome in humans. PLoS One (2012) 1.02
Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis. Antioxid Redox Signal (2009) 1.01
Clinical applications of remote ischemic preconditioning. Cardiol Res Pract (2012) 0.98
Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop. Basic Res Cardiol (2014) 0.98
Reductions in mitochondrial O(2) consumption and preservation of high-energy phosphate levels after simulated ischemia in chronic hibernating myocardium. Am J Physiol Heart Circ Physiol (2009) 0.97
Effect of remote ischemic preconditioning on hepatic microcirculation and function in a rat model of hepatic ischemia reperfusion injury. HPB (Oxford) (2009) 0.97
Remote ischemic conditioning: from bench to bedside. Front Physiol (2012) 0.94
Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning. PLoS One (2013) 0.93
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection. Cell (2016) 0.93
Postoperative neurocognitive dysfunction in patients undergoing cardiac surgery after remote ischemic preconditioning: a double-blind randomized controlled pilot study. PLoS One (2013) 0.89
Hypoxia-inducible factor as an angiogenic master switch. Front Pediatr (2015) 0.88
Association between clinical presentations before myocardial infarction and coronary mortality: a prospective population-based study using linked electronic records. Eur Heart J (2014) 0.88
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol (2016) 0.87
Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the Heart. Oxid Med Cell Longev (2015) 0.87
Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway. Br J Pharmacol (2005) 0.87
Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation. J Transplant (2012) 0.86
Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning. Basic Res Cardiol (2016) 0.86
Clinical applications of remote ischaemic preconditioning in native and transplant acute kidney injury. Pediatr Nephrol (2014) 0.84
Remote ischaemic conditioning: cardiac protection from afar. Anaesthesia (2015) 0.83
Partial hindlimb occlusion reduced the susceptibility to sustained ventricular tachycardia in conscious rats. J Cardiovasc Pharmacol Ther (2009) 0.83
Therapeutic potential of ischaemic preconditioning. Br J Clin Pharmacol (2000) 0.82
Neural mechanisms of cardioprotection. Physiology (Bethesda) (2014) 0.82
New approaches to neuroprotection in infant heart surgery. Pediatr Res (2010) 0.81
Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery. J Saudi Heart Assoc (2013) 0.81
Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interact Cardiovasc Thorac Surg (2012) 0.81
Cardiac phosphoproteomics during remote ischemic preconditioning: a role for the sarcomeric Z-disk proteins. Biomed Res Int (2014) 0.81
Is nitrite the circulating endocrine effector of remote ischemic preconditioning? Circ Res (2014) 0.80
The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury. Heart (2007) 0.80
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences. World J Cardiol (2015) 0.80
From Protecting the Heart to Improving Athletic Performance - the Benefits of Local and Remote Ischaemic Preconditioning. Cardiovasc Drugs Ther (2015) 0.80
Cardioprotection acquired through exercise: the role of ischemic preconditioning. Curr Cardiol Rev (2014) 0.79
Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning--a word of caution. PLoS One (2014) 0.79
Cardioprotection with adenosine: 'a riddle wrapped in a mystery'. Br J Pharmacol (2005) 0.79
RISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardioprotection. PLoS One (2014) 0.79
Full steam ahead with remote ischemic conditioning for stroke. Transl Stroke Res (2014) 0.79
Identifying the Source of a Humoral Factor of Remote (Pre)Conditioning Cardioprotection. PLoS One (2016) 0.79
Remote limb ischemic conditioning enhances motor learning in healthy humans. J Neurophysiol (2015) 0.79
Cardioprotection by remote ischemic conditioning and its signal transduction. Pflugers Arch (2016) 0.78
Liver ischemia preconditions the heart against ischemia-reperfusion arrhythmias. Iran J Basic Med Sci (2015) 0.78
Remote preconditioning in normal and hypertrophic rat hearts. J Cardiothorac Surg (2011) 0.78
Advances in the pathogenesis of cardiorenal syndrome type 3. Oxid Med Cell Longev (2015) 0.78
Conditioning the heart to prevent myocardial reperfusion injury during PPCI. Eur Heart J Acute Cardiovasc Care (2012) 0.78
Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning. Cardiovasc Res (2016) 0.78
Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation (2003) 0.77
Remote ischemic preconditioning reduces myocardial ischemia/reperfusion injury. J Surg Res (2009) 0.77
Remote ischemic preconditioning in patients with intermittent claudication. Clinics (Sao Paulo) (2013) 0.77
Remote vs. local ischaemic preconditioning in the rat heart: infarct limitation, suppression of ischaemic arrhythmia and the role of reactive oxygen species. Int J Exp Pathol (2016) 0.77
Remote ischaemic conditioning-a new paradigm of self-protection in the brain. Nat Rev Neurol (2015) 0.77
Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Coronary Artery Bypass Grafting Undergoing: A Randomized Clinical Trial. Iran J Med Sci (2016) 0.77
Biological networks in ischemic tolerance - rethinking the approach to clinical conditioning. Transl Stroke Res (2013) 0.76
Anti-inflammatory effects of limb ischaemic preconditioning are mediated by sensory nerve activation in rats. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.76
Remote ischaemic conditioning-therapeutic opportunities in renal medicine. Nat Rev Nephrol (2013) 0.76
Remote ischaemic preconditioning does not alter perioperative cytokine production in high-risk cardiac surgery. Heart Asia (2012) 0.75
Combination of remote ischemic perconditioning and remote ischemic postconditioning fails to increase protection against myocardial ischemia/reperfusion injury, compared with either alone. Mol Med Rep (2015) 0.75
Remote ischemic perconditioning attenuates ischemia/reperfusion-induced downregulation of AQP2 in rat kidney. Physiol Rep (2016) 0.75
Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks. J Immunol Res (2015) 0.75
Astragaloside IV enhances cardioprotection of remote ischemic conditioning after acute myocardial infarction in rats. Am J Transl Res (2016) 0.75
Remote ischemic perconditioning prevents liver transplantation-induced ischemia/reperfusion injury in rats: Role of ROS/RNS and eNOS. World J Gastroenterol (2017) 0.75
Mechanical post-conditioning in STEMI patients undergoing primary percutaneous coronary intervention. J Saudi Heart Assoc (2014) 0.75
Perioperative clinical variables and long-term survival following vascular surgery. World J Cardiol (2014) 0.75
Remote Ischemic Preconditioning for Prevention of Acute Kidney Injury in Patients Undergoing On-Pump Cardiac Surgery: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.75
Overview of Experimental and Clinical Findings regarding the Neuroprotective Effects of Cerebral Ischemic Postconditioning. Biomed Res Int (2017) 0.75
Coronary vasoregulation in health and disease. Can J Cardiol (2007) 0.75
Neurogenic pathways in remote ischemic preconditioning induced cardioprotection: Evidences and possible mechanisms. Korean J Physiol Pharmacol (2017) 0.75
Myocardial infarct size limiting effect of low body temperature in rats depends on the duration of coronary artery occlusion. Circulation (1997) 0.75
Protective effects of remote ischemic preconditioning in isolated rat hearts. Int J Clin Exp Med (2015) 0.75
Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives. Heart Fail Rev (2016) 0.75
Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis. BMJ (2016) 0.75
Effect of Pneumoperitoneum on Renal Function and Physiology in Patients Undergoing Robotic Renal Surgery. Curr Urol (2016) 0.75
Remote ischemic preconditioning triggers changes in autonomic nervous system activity: implications for cardioprotection. Physiol Rep (2017) 0.75
Remote ischaemic preconditioning suppresses endogenous plasma nitrite during ischaemia-reperfusion: a randomised controlled crossover pilot study. Br J Clin Pharmacol (2017) 0.75
Harnessing the preconditioning phenomenon: does remote organ ischaemia provide the answer? Heart (2005) 0.75
Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus. Nat Commun (2017) 0.75
Influence of cardiac nerve status on cardiovascular regulation and cardioprotection. World J Cardiol (2017) 0.75
Preconditioning in Neuroprotection: From Hypoxia to Ischemia. Prog Neurobiol (2017) 0.75
Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension (1994) 1.87
Ischaemic preconditioning by partial occlusion without intermittent reperfusion. Cardiovasc Res (1994) 1.44
Invasive coronary imaging in animal models of atherosclerosis. Neth Heart J (2011) 1.40
Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int (2001) 1.36
Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation (1998) 1.27
5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br J Pharmacol (1985) 1.25
5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor. Br J Pharmacol (1988) 1.25
Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ Res (2004) 1.24
Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation (1998) 1.16
Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol (1998) 1.16
Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol (1982) 1.15
Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. Circ Res (1992) 1.13
Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension (1997) 1.13
Transmission of ultrasonic contrast through the lungs. Ultrasound Med Biol (1981) 1.07
Has melatonin a future as a cardioprotective agent? Cardiovasc Drugs Ther (2001) 1.07
Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart (2000) 1.06
Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties. Eur J Pharmacol (1986) 1.06
Antiarrhythmic and hemodynamic actions of flecainide acetate (R-818) in the ischemic porcine heart. J Cardiovasc Pharmacol (1980) 1.05
DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol (1991) 1.05
Increasing arterial wall injury after long-term implantation of two types of stent in a porcine coronary model. Eur Heart J (1998) 1.04
Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation (2000) 1.04
Transmural bioenergetic responses of normal myocardium to high workstates. Am J Physiol (1995) 1.03
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. J Mol Cell Cardiol (2000) 1.02
Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc Res (1998) 1.02
Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J (2011) 1.01
Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. A 31P NMR spectroscopic study. Circulation (1995) 1.01
Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise. Am J Physiol (1998) 1.00
N-(3-acetylaminophenyl)piperazine hydrochloride (BEA 1654), a putative 5-HT1 agonist, causes constriction of arteriovenous anastomoses and dilatation of arterioles. Eur J Pharmacol (1985) 1.00
Tissue blood flow and localization of arteriovenous anastomoses in pigs with microspheres of four different sizes. Pflugers Arch (1985) 1.00
ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res (1998) 1.00
Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res (1994) 0.99
Organ blood flow protection in hypertension and congestive heart failure. Am J Med (1993) 0.99
Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward beta-adrenergic control. Circ Res (1998) 0.98
Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307. Eur J Pharmacol (1984) 0.97
Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol (1992) 0.96
High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner. MAGMA (2004) 0.96
Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation (2000) 0.95
Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors. Br J Pharmacol (1984) 0.95
Subcellular localization of angiotensin II in kidney and adrenal. J Hypertens (2001) 0.92
In vitro imaging of single living human umbilical vein endothelial cells with a clinical 3.0-T MRI scanner. MAGMA (2005) 0.92
The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing. Eur J Pharmacol (1980) 0.92
Role of K(ATP)(+) channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine. Am J Physiol Heart Circ Physiol (2001) 0.92
The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion. Cardiovasc Drugs Ther (1992) 0.92
Cardiac remodeling and contractile function in acid alpha-glucosidase knockout mice. Physiol Genomics (2001) 0.91
Carotid haemodynamics in pigs during infusions of 8-OH-DPAT: reduction in arteriovenous shunting is mediated by 5-HT1-like receptors. Br J Pharmacol (1989) 0.91
Coordinated expression of heme oxygenase-1 and ubiquitin in the porcine heart subjected to ischemia and reperfusion. Mol Cell Biochem (1996) 0.91
Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.91
Nitric oxide contributes to the regulation of vasomotor tone but does not modulate O(2)-consumption in exercising swine. Cardiovasc Res (2000) 0.91
Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation (1996) 0.91
Domestic pigs in the study of myocardial ischemia. Eur Heart J (1983) 0.90
Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.90
Coronary stenting with a new, radiopaque, balloon-expandable endoprosthesis in pigs. Circulation (1991) 0.89
Systemic and regional myocardial responses to AR-L 115 BS, a positive inotropic imidazo-pyridine, in the absence or in the presence of the bradycardiac action of alinidine. Basic Res Cardiol (1981) 0.89
Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral-dependent myocardial region. J Am Coll Cardiol (1998) 0.89
Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc Res (1996) 0.89
Regional myocardial perfusion and wall thickness and arteriovenous shunting after ergotamine administration to pigs with a fixed coronary stenosis. J Cardiovasc Pharmacol (1980) 0.89
Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol (1992) 0.89
Rapid ventricular pacing produces myocardial protection by nonischemic activation of KATP+ channels. Circulation (1996) 0.89
The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs. Br J Pharmacol (1990) 0.88
In-vivo validation of on-line and off-line geometric coronary measurements using insertion of stenosis phantoms in porcine coronary arteries. Cathet Cardiovasc Diagn (1992) 0.88
Cardiovascular profile of the new dihydropyridine derivative S12968. Eur J Pharmacol (1991) 0.88
Significance of haemodynamic variables in coronary care unit for prediction of survival after acute myocardial infarction. Br Heart J (1983) 0.88
Minimal impairment of myocardial blood flow responses to exercise in the remodeled left ventricle early after myocardial infarction, despite significant hemodynamic and neurohumoral alterations. Cardiovasc Res (2001) 0.88
Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts. Biochem Biophys Res Commun (1994) 0.88
Usefulness of pimobendan in the treatment of heart failure. Arzneimittelforschung (1986) 0.87
The effect of the stable prostacyclin analogue ZK 36374 on experimental coronary thrombosis in the pig. Thromb Res (1984) 0.87
Poor vasoconstrictor response to adrenergic stimulation in the arteriovenous anastomoses present in the carotid vascular bed of young Yorkshire pigs. Arch Int Pharmacodyn Ther (1984) 0.87
Short-term survival after acute myocardial infarction predicted by hemodynamic parameters. Circulation (1975) 0.87
Stroke volume from central aortic pressure? A critical assessment of the various formulae as to their clinical value. Basic Res Cardiol (1976) 0.87
Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. Hypertension (1997) 0.87
Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 1: Cardiovascular progenitor cells, their functions and sources. Neth Heart J (2008) 0.86
Myofibrillar Ca2+ sensitization predominantly enhances function and mechanical efficiency of stunned myocardium. Circulation (1994) 0.86
Nimodipine-induced changes in the distribution of carotid blood flow and cardiac output in pentobarbitone-anaesthetized pigs. Br J Pharmacol (1986) 0.86
Iloprost (ZK 36374) enhances recovery of regional myocardial function during reperfusion after coronary artery occlusion in the pig. Br J Pharmacol (1986) 0.86
Autonomic control of cardiovascular performance and whole body O2 delivery and utilization in swine during treadmill exercise. Cardiovasc Res (1998) 0.86
The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade. Br J Pharmacol (1986) 0.86
Antiarrhythmic, metabolic and hemodynamic effects of Org 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one-hydrochloride) after coronary flow reduction in pigs. J Pharmacol Exp Ther (1978) 0.86
Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts. Cardiovasc Res (2000) 0.86
Decreased incidence of ventricular fibrillation after an acute coronary artery ligation in exercised pigs. Basic Res Cardiol (1983) 0.86
AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction. Am J Physiol Heart Circ Physiol (2001) 0.85
Transfer of cardiovascular forces through the body. Med Biol Eng (1974) 0.85